$EMLR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Talon Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Talon Therapeutics, Inc.. Get notifications about new insider transactions in Talon Therapeutics, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 18 2006 | EMLR | Talon Therapeutics ... | KIER ISAAC | Director | Buy | P | 6.44 | 1,400 | 9,016 | 2,400 | 1,000 to 2.4 K (+140.00 %) |
| Jul 18 2006 | EMLR | Talon Therapeutics ... | KIER ISAAC | Director | Grant | A | 0.00 | 10,000 | 0 | 81,748 | 71.7 K to 81.7 K (+13.94 %) |
| Jul 11 2006 | EMLR | Talon Therapeutics ... | WEISER MICHAEL | Director | Buy | P | 7.91 | 200 | 1,582 | 551,667 | 551.5 K to 551.7 K (+0.04 %) |
| Jul 11 2006 | EMLR | Talon Therapeutics ... | WEISER MICHAEL | Director | Buy | P | 7.95 | 300 | 2,385 | 551,467 | 551.2 K to 551.5 K (+0.05 %) |
| Jul 11 2006 | EMLR | Talon Therapeutics ... | WEISER MICHAEL | Director | Buy | P | 7.85 | 300 | 2,355 | 551,167 | 550.9 K to 551.2 K (+0.05 %) |
| Jul 11 2006 | EMLR | Talon Therapeutics ... | WEISER MICHAEL | Director | Buy | P | 7.83 | 200 | 1,566 | 550,867 | 550.7 K to 550.9 K (+0.04 %) |
| Jul 07 2006 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Option Exercise | A | 1.68 | 194,568 | 327,653 | 194,568 | |
| Jul 07 2006 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Option Exercise | D | 0.34 | 194,568 | 65,569 | 0 | |
| Jul 07 2006 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Option Exercise | A | 1.68 | 79,658 | 134,144 | 79,658 | |
| Jul 07 2006 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Option Exercise | D | 0.34 | 79,658 | 26,845 | 0 | |
| Jul 07 2006 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Option Exercise | A | 0.83 | 184,555 | 153,734 | 184,555 | |
| Jul 07 2006 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Option Exercise | D | 0.17 | 184,555 | 30,821 | 0 | |
| Jul 07 2006 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Option Exercise | A | 0.83 | 329,016 | 274,070 | 329,016 | |
| Jul 07 2006 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Option Exercise | D | 0.17 | 329,016 | 54,946 | 0 | |
| Jul 07 2006 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Grant | A | 0.00 | 74,887 | 0 | 602,631 | 527.7 K to 602.6 K (+14.19 %) |
| Jul 07 2006 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Grant | A | 0.00 | 325,000 | 0 | 527,744 | 202.7 K to 527.7 K (+160.30 %) |
| Jul 07 2006 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Grant | A | 0.00 | 85,000 | 0 | 287,774 | 202.8 K to 287.8 K (+41.92 %) |
| Jul 07 2006 | EMLR | Talon Therapeutics ... | Vitale Fred | VP - Business Devel ... | Option Exercise | A | 0.83 | 141,007 | 117,459 | 141,007 | |
| Jul 07 2006 | EMLR | Talon Therapeutics ... | Vitale Fred | VP - Business Devel ... | Option Exercise | D | 0.34 | 141,007 | 47,378 | 0 | |
| Jul 07 2006 | EMLR | Talon Therapeutics ... | Vitale Fred | VP - Business Devel ... | Grant | A | 0.00 | 7,377 | 0 | 136,386 | 129 K to 136.4 K (+5.72 %) |
| May 19 2006 | EMLR | Talon Therapeutics ... | KIER ISAAC | Director | Buy | P | 9.07 | 11,000 | 99,770 | 151,528 | 140.5 K to 151.5 K (+7.83 %) |
| May 18 2006 | EMLR | Talon Therapeutics ... | Vitale Fred | VP - Business Devel ... | Buy | P | 9.07 | 55,100 | 499,757 | 129,009 | 73.9 K to 129 K (+74.55 %) |
| May 18 2006 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Buy | P | 9.07 | 5,500 | 49,885 | 202,744 | 197.2 K to 202.7 K (+2.79 %) |
| May 18 2006 | EMLR | Talon Therapeutics ... | NIELSEN TYLER MARSHALL | Controller | Buy | P | 9.00 | 100 | 900 | 100 | 0 to 100 |
| May 18 2006 | EMLR | Talon Therapeutics ... | NIELSEN TYLER MARSHALL | Controller | Buy | P | 9.00 | 110 | 990 | 110 | 0 to 110 |
| May 11 2006 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Option Exercise | M | 1.57 | 5,859 | 9,199 | 0 | |
| May 11 2006 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Option Exercise | M | 1.57 | 5,859 | 9,199 | 0 | |
| May 11 2006 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Option Exercise | M | 0.17 | 164,508 | 27,473 | 329,016 | |
| May 11 2006 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Buy | M | 1.57 | 5,859 | 9,199 | 33,336 | 27.5 K to 33.3 K (+21.32 %) |
| May 11 2006 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Buy | M | 1.57 | 5,859 | 9,199 | 197,244 | 191.4 K to 197.2 K (+3.06 %) |
| May 11 2006 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Buy | M | 0.17 | 164,508 | 27,473 | 191,385 | 26.9 K to 191.4 K (+612.08 %) |
| May 11 2006 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Gift | G | 0.00 | 5,000 | 0 | 26,877 | 31.9 K to 26.9 K (-15.69 %) |
| Mar 27 2006 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Buy | P | 10.63 | 1,000 | 10,630 | 31,877 | 30.9 K to 31.9 K (+3.24 %) |
| Feb 10 2006 | EMLR | Talon Therapeutics ... | WEISER MICHAEL | Director | Option Exercise | J | 1.57 | 29,296 | 45,995 | 29,296 | |
| Mar 22 2006 | EMLR | Talon Therapeutics ... | Iparraguirre John | Vice President, CFO | Buy | P | 10.58 | 470 | 4,973 | 10,270 | 9.8 K to 10.3 K (+4.80 %) |
| Nov 15 2005 | EMLR | Talon Therapeutics ... | Iparraguirre John | Controller | Option Exercise | A | 4.75 | 50,000 | 237,500 | 50,000 | |
| Nov 15 2005 | EMLR | Talon Therapeutics ... | Iparraguirre John | Controller | Gift | G | 0.00 | 100 | 0 | 100 | 0 to 100 |
| Nov 15 2005 | EMLR | Talon Therapeutics ... | Iparraguirre John | Controller | Gift | G | 0.00 | 200 | 0 | 9,800 | 10 K to 9.8 K (-2.00 %) |
| Nov 15 2005 | EMLR | Talon Therapeutics ... | Vitale Fred | VP - Business Devel ... | Option Exercise | A | 4.75 | 150,000 | 712,500 | 150,000 | |
| Nov 15 2005 | EMLR | Talon Therapeutics ... | Berk Gregory | Chief Medical Offic ... | Option Exercise | A | 4.75 | 200,000 | 950,000 | 200,000 | |
| Nov 15 2005 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Option Exercise | A | 4.75 | 155,179 | 737,100 | 155,179 | |
| Nov 15 2005 | EMLR | Talon Therapeutics ... | WEISER MICHAEL | Director | Option Exercise | A | 4.75 | 40,000 | 190,000 | 40,000 | |
| Nov 15 2005 | EMLR | Talon Therapeutics ... | Rosenberg Leon E | Director | Option Exercise | A | 4.75 | 40,000 | 190,000 | 40,000 | |
| Nov 15 2005 | EMLR | Talon Therapeutics ... | KIER ISAAC | Director | Option Exercise | A | 4.75 | 40,000 | 190,000 | 40,000 | |
| Nov 15 2005 | EMLR | Talon Therapeutics ... | Belldegrun Arie | Director | Option Exercise | A | 4.75 | 40,000 | 190,000 | 40,000 | |
| Oct 21 2005 | EMLR | Talon Therapeutics ... | Vitale Fred | VP - Business Devel ... | Option Exercise | P | 5.80 | 8,714 | 50,541 | 8,714 | |
| Oct 21 2005 | EMLR | Talon Therapeutics ... | Vitale Fred | VP - Business Devel ... | Gift | G | 0.00 | 1,000 | 0 | 1,000 | 0 to 1,000 |
| Oct 21 2005 | EMLR | Talon Therapeutics ... | Vitale Fred | VP - Business Devel ... | Buy | P | 4.59 | 43,572 | 199,995 | 73,909 | 30.3 K to 73.9 K (+143.63 %) |
| Oct 21 2005 | EMLR | Talon Therapeutics ... | Vitale Fred | VP - Business Devel ... | Gift | G | 0.00 | 4,100 | 0 | 30,337 | 34.4 K to 30.3 K (-11.91 %) |
| Oct 21 2005 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Option Exercise | P | 5.80 | 1,089 | 6,316 | 1,089 | |
| Oct 21 2005 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Option Exercise | P | 5.80 | 1,089 | 6,316 | 1,089 | |
| Oct 21 2005 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Buy | P | 4.59 | 5,446 | 24,997 | 27,477 | 22 K to 27.5 K (+24.72 %) |
| Oct 21 2005 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Gift | G | 0.00 | 500 | 0 | 22,031 | 21.5 K to 22 K (+2.32 %) |
| Oct 21 2005 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Gift | G | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
| Oct 21 2005 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Buy | P | 4.59 | 5,446 | 24,997 | 30,877 | 25.4 K to 30.9 K (+21.41 %) |
| Oct 21 2005 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Gift | G | 0.00 | 3,100 | 0 | 25,431 | 28.5 K to 25.4 K (-10.87 %) |
| Oct 21 2005 | EMLR | Talon Therapeutics ... | KIER ISAAC | Director | Option Exercise | P | 5.80 | 4,357 | 25,271 | 4,357 | |
| Oct 21 2005 | EMLR | Talon Therapeutics ... | KIER ISAAC | Director | Option Exercise | P | 5.80 | 10,893 | 63,179 | 10,893 | |
| Oct 21 2005 | EMLR | Talon Therapeutics ... | KIER ISAAC | Director | Buy | P | 4.59 | 21,786 | 99,998 | 140,528 | 118.7 K to 140.5 K (+18.35 %) |
| Oct 21 2005 | EMLR | Talon Therapeutics ... | KIER ISAAC | Director | Buy | P | 4.59 | 54,446 | 249,907 | 661,581 | 607.1 K to 661.6 K (+8.97 %) |
| Jul 27 2005 | EMLR | Talon Therapeutics ... | Skibsted Russell | Chief Financial Off ... | Option Exercise | A | 2.39 | 150,000 | 358,500 | 150,000 | |
| Jul 18 2005 | EMLR | Talon Therapeutics ... | Belldegrun Arie | Director | Option Exercise | A | 1.65 | 20,000 | 33,000 | 20,000 | |
| Jul 18 2005 | EMLR | Talon Therapeutics ... | Belldegrun Arie | Director | Option Exercise | A | 1.33 | 20,000 | 26,600 | 20,000 | |
| Jul 18 2005 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Buy | P | 1.63 | 2,000 | 3,260 | 28,531 | 26.5 K to 28.5 K (+7.54 %) |
| Jul 18 2005 | EMLR | Talon Therapeutics ... | KIER ISAAC | Director | Option Exercise | A | 1.65 | 20,000 | 33,000 | 20,000 | |
| Jul 18 2005 | EMLR | Talon Therapeutics ... | WEISER MICHAEL | Director | Option Exercise | A | 1.65 | 20,000 | 33,000 | 20,000 | |
| Jul 18 2005 | EMLR | Talon Therapeutics ... | WEISER MICHAEL | Director | Option Exercise | A | 1.33 | 20,000 | 26,600 | 20,000 | |
| Jul 18 2005 | EMLR | Talon Therapeutics ... | Rosenberg Leon E | Director | Option Exercise | A | 1.65 | 20,000 | 33,000 | 20,000 | |
| Jul 18 2005 | EMLR | Talon Therapeutics ... | Rosenberg Leon E | Director | Option Exercise | A | 1.33 | 20,000 | 26,600 | 20,000 | |
| Apr 29 2005 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Option Exercise | P | 1.57 | 5,859 | 9,199 | 5,859 | |
| Apr 29 2005 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Option Exercise | P | 1.57 | 5,859 | 9,199 | 5,859 | |
| Apr 29 2005 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Buy | P | 1.28 | 19,531 | 25,000 | 21,531 | 2 K to 21.5 K (+976.55 %) |
| Apr 29 2005 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Buy | P | 1.28 | 19,531 | 25,000 | 26,531 | 7 K to 26.5 K (+279.01 %) |
| May 02 2005 | EMLR | Talon Therapeutics ... | KIER ISAAC | Director | Option Exercise | P | 1.57 | 23,437 | 36,796 | 23,437 | |
| May 02 2005 | EMLR | Talon Therapeutics ... | KIER ISAAC | Director | Option Exercise | P | 1.57 | 46,875 | 73,594 | 46,875 | |
| May 02 2005 | EMLR | Talon Therapeutics ... | KIER ISAAC | Director | Option Exercise | P | 1.57 | 5,859 | 9,199 | 5,859 | |
| May 02 2005 | EMLR | Talon Therapeutics ... | KIER ISAAC | Director | Buy | P | 1.28 | 19,531 | 25,000 | 72,748 | 53.2 K to 72.7 K (+36.70 %) |
| May 02 2005 | EMLR | Talon Therapeutics ... | KIER ISAAC | Director | Buy | P | 1.28 | 78,125 | 100,000 | 120,342 | 42.2 K to 120.3 K (+185.06 %) |
| May 02 2005 | EMLR | Talon Therapeutics ... | KIER ISAAC | Director | Buy | P | 1.28 | 156,250 | 200,000 | 607,135 | 450.9 K to 607.1 K (+34.65 %) |
| Apr 29 2005 | EMLR | Talon Therapeutics ... | Vitale Fred | VP - Business Devel ... | Option Exercise | P | 1.57 | 7,031 | 11,039 | 7,031 | |
| Apr 29 2005 | EMLR | Talon Therapeutics ... | Vitale Fred | VP - Business Devel ... | Buy | P | 1.28 | 23,437 | 29,999 | 34,437 | 11 K to 34.4 K (+213.06 %) |
| Apr 21 2005 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Option Exercise | A | 1.33 | 126,501 | 168,246 | 126,501 | |
| Apr 21 2005 | EMLR | Talon Therapeutics ... | Iparraguirre John | Controller | Option Exercise | A | 1.33 | 40,000 | 53,200 | 40,000 | |
| Apr 21 2005 | EMLR | Talon Therapeutics ... | Vitale Fred | VP - Business Devel ... | Option Exercise | A | 1.33 | 85,000 | 113,050 | 85,000 | |
| Jan 27 2005 | EMLR | Talon Therapeutics ... | KIER ISAAC | Director | Grant | A | 0.00 | 10,000 | 0 | 53,217 | 43.2 K to 53.2 K (+23.14 %) |
| Jan 27 2005 | EMLR | Talon Therapeutics ... | Iparraguirre John | Controller | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
| Jan 27 2005 | EMLR | Talon Therapeutics ... | Vitale Fred | VP - Business Devel ... | Grant | A | 0.00 | 10,000 | 0 | 11,000 | 1,000 to 11 K (+1,000.00 %) |
| Jan 27 2005 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Grant | A | 0.00 | 5,000 | 0 | 7,000 | 2 K to 7 K (+250.00 %) |
| Jan 21 2005 | EMLR | Talon Therapeutics ... | Vitale Fred | VP - Business Devel ... | Buy | P | 2.40 | 1,000 | 2,400 | 1,000 | 0 to 1,000 |
| Jan 21 2005 | EMLR | Talon Therapeutics ... | KIER ISAAC | Director | Buy | P | 2.50 | 1,000 | 2,500 | 43,217 | 42.2 K to 43.2 K (+2.37 %) |
| Jan 21 2005 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Buy | P | 2.45 | 2,000 | 4,900 | 2,000 | 0 to 2 K |
| Jan 21 2005 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Buy | P | 2.50 | 2,000 | 5,000 | 2,000 | 0 to 2 K |
| Nov 04 2004 | EMLR | Talon Therapeutics ... | Berk Gregory | Chief Medical Offic ... | Option Exercise | A | 2.39 | 150,000 | 358,500 | 150,000 | |
| Nov 04 2004 | EMLR | Talon Therapeutics ... | Berk Gregory | Chief Medical Offic ... | Option Exercise | A | 2.39 | 150,000 | 358,500 | 150,000 |